This site is intended for Healthcare professionals only.

Cipla, Pfizer and DRL among 66 drug firms that fail quality test


Cipla, Pfizer and DRL among  66 drug firms that fail quality test

Some of Major drug companies like Pfizer, Alembic Pharma, Cipla, Dr Reddy’s Laboratories & Zydus Healthcare are among 66 drug companies  that have failed the test for Not of Standard Quality (NSQ) drugs, according to a report released by CDSCO.

In a bid to  bring down the proportion of its substandard drugs to 2% over the next three years to match global standards, National Institute of Biologicals was deputed by Ministry of Health and Family Welfare to conduct the National Drug Survey  across the country. The institute was asked to   check and ascertain the proportion of drug samples failing in Quality testing and tabulate them.

The survey, conducted to check the proportion of substandard drugs in the country, had tested 47,012 samples from 1,719 manufacturing units, CDSCO said. Around 3.16% of these samples were found to be not of standard quality. The estimated percentage of NSQ drugs from government sources was 10.02% and the percentage of spurious drugs was 0.05%. Globally, the acceptable rate is around 2%.

Joint Secretary (Regulation), Ministry of Health & Family Welfare in general review meeting about CDSCO, held on 06.07.2017 decided that the list of drug manufacturers where more than five samples have been failed, be put on CDSCO Website separately.

Accordingly the  report was displayed which states  that Pfizer has failed the test for 25 samples, Dr Reddy’s Laboratories and Alembic have 9 NSQ samples each. In addition to this seven samples  of Cipla, and six samples of Zydus Healthcare have failed the government’s test.

Find the attachment for the same.

http://www.cdsco.nic.in/writereaddata/National%20Drug%20Survey.pdf



Source: self
2 comment(s) on Cipla, Pfizer and DRL among 66 drug firms that fail quality test

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted
  1. And OUR Indian government asking to write cheapest drugs to the patients. If the quality of medicine is not proper it is equivalent to giving a wrong medication. Doctors will not understand why the disease is not controlled by the proper medication. Patient may land up in other complications or adverse drug reactions which will cost more than proper quality medication(of course quality comes with cost only which needs more effort). Government and media should close their minds on this issue, India is still much cheaper than any other country in medical healthcare. Don\’t try to control medical fraternity, instead control at root cause level ( Controlling Pharma Companies, Controlling Medical Study Fees etc) which automatically brings better future.

  2. And OUR Indian government asking to write cheapest drugs to the patients. If the quality of medicine is not proper it is equivalent to giving a wrong medication. Doctors will not understand why the disease is not controlled by the proper medication. Patient may land up in other complications or adverse drug reactions which will cost more than proper quality medication(of course quality comes with cost only which needs more effort). Government and media should close their minds on this issue, India is still much cheaper than any other country in medical healthcare. Don\’t try to control medical fraternity, instead control at root cause level ( Controlling Pharma Comapanies, Controlling Medical Study Fees etc) which automatically brings better future.